StackRanksFinance newsletter earnings, ranked by estimated MRR
Public revenue estimates for tracked finance newsletters.
| Rank | Publication | MRR | ARR | YoY |
|---|
Public revenue estimates for tracked finance newsletters.
| Rank | Publication | MRR | ARR | YoY |
|---|
Tracked Publication
Biotech Investing Newsletter: 2x your money, one biotech catalyst at a time A biotech analyst (ex-Deutsche Bank, ex-consulting, PhD) dissects biotech catalysts worth investing in!
Earnings Estimates (Gross MRR)
Subscriber Composition
Composition not available yet
Subscriber mix will appear here once we have enough snapshot data for this publication.
Revenue Estimates (Gross MRR)
$248.4Range $82.8 – $819.7
Free Subscribers
No subscriber history yet
Free subscriber trends will appear here once we have enough monthly snapshots.
Paid Subscribers (est.)
30Post Activity
2 posts/moMedian Engagement per Post
Reactions
5
over 27 posts
Comments
0
over 27 posts
Restacks
2
over 27 posts
Paid Plans
Included in all plans
Recent Posts
High Risk, High Returns (Biotech Investing Newsletter) turns 1! Gifts for all!
A piece arguing that Substack “will collapse” went viral last week. It’s a compelling read. In our sector of finance, it’s very likely wrong.
Access link inside
High Risk, High Returns (Biotech Investing Newsletter): mapping our newsletter's full set of features for new and old subscribers. Start here!